← Back to headlines
Intellia Outlines 2026 Lonvo-z Launch Plans After FDA Lifts Clinical Hold
Intellia Therapeutics has detailed its plans for the 2026 launch of lonvo-z, following the FDA's decision to lift the clinical hold on its MAGNITUDE-2 trial.
27 Feb, 02:48 — 27 Feb, 02:48
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
NFA relaxes palay-buying rules to benefit farmers
just now
Venezuela suspends 19 oil, gas production-sharing contracts signed under Maduro, sources say
just now
Hungary Considers Adria Pipeline as Alternative to Druzhba
7m ago
Netflix surprisingly withdrew from Warner Bros. deal – Paramount made a better offer
10m ago